Novo Nordisk A/S (NNO2)
WBAG • NNO2 • DK0062498333
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 124 days to cover, cost to borrow 1.56%. Sign up for live short interest data.
Market Cap
180b USD | # 94 in AT
Volume
6.12k shares | 7.25m USD
Shares Outstanding
3.33b
Free Float Shares
94.64% | 3.16b
